Early hematological response and safety of isatuximab, pomalidomide and dexamethasone (IsaPd) in relapsed AL amyloidosis: interim results of the IsaMYP phase II study. PA153 (#195)
crossref（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined